| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |